Showing results (401-410 of 656) with videos related to

Sort By:
Pageof 66
American Journal of Physiology. Heart and Circulatory Physiology|June 1, 2005
Anti-tumor necrosis factor-{alpha} therapies attenuate adaptive arteriogenesis in the rabbitSebastian Grundmann, Imo Hoefer, Susann Ulusans, et al.
Plos One|September 23, 2014
Pronounced effects of HERG-blockers E-4031 and erythromycin on APD, spatial APD dispersion and triangulation in transgenic long-QT type 1 rabbitsDavid Ziupa, Julia Beck, Gerlind Franke, et al.
Frontiers in Neurology|October 19, 2023
Left atrial area index provides the best prediction of atrial fibrillation in ischemic stroke patients: results from the LAETITIA observational studyAngelika Alonso, Josephine Kraus, Anne Ebert, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 3, 2022
Should HFrEF patients with NYHA class II expect benefit from CCM therapy? Results from the MAINTAINED observational studyChristian Fastner, Goekhan Yuecel, Svetlana Hetjens, et al.
Research and Practice in Thrombosis and Haemostasis|October 19, 2019
Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndromeCharlotte Grosdidier, Kelly D Blanz, Pierre Deharo, et al.
Thrombosis Research|November 28, 2015
TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatranChristoph B Olivier, Patrick Weik, Melanie Meyer, et al.
Heart (British Cardiac Society)|February 20, 2020
Outcomes of transcatheter aortic valve implantations in high-volume or low-volume centres in GermanyVera Oettinger, Klaus Kaier, Timo Heidt, et al.
Journal of Thrombosis and Thrombolysis|June 16, 2020
Cardiomyocyte microvesicles: proinflammatory mediators after myocardial ischemia?Patrick Malcolm Siegel, Judith Schmich, Georg Barinov, et al.
American Heart Journal|November 9, 2016
A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart diseaseRobert C Welsh, Matthew T Roe, Philippe Gabriel Steg, et al.
Molecular Imaging|August 19, 2008
Functionalized magnetic resonance contrast agent selectively binds to glycoprotein IIb/IIIa on activated human platelets under flow conditions and is detectable at clinically relevant field strengthsConstantin von Zur Muhlen, Dominik von Elverfeldt, Robin Paul Choudhury, et al.
Pageof 66